Press Releases Alzinova AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:15:24 2024-05-10 EDT			5-day change	1st Jan Change
1.126 ^SEK	-2.93%		-10.78%	-62.90%

04-25	Sweden’s Alzinova Says CEO to Step Down by July-end	MT
04-25	Kristina Torfgård Leaves the CEO Position At Alzinova Ab, Effective July 31, 2024	CI

Alzinova publishes the Annual Report for 2023	05-07	AQ
NOTICE OF ANNUAL GENERAL MEETING IN ALZINOVA AB (PUBL)	04-26	AQ
The Board of Directors resolves on a rights issue of shares of approximately SEK 34.4 million	04-26	AQ
Kristina Torfgård leaves the CEO position at Alzinova AB in July 2024	04-25	AQ
Alzinova: In-depth analysis shows positive trend in biomarkers	04-11	AQ
Alzinova - All patients in the extension part of the phase 1b study have received their last dose	04-04	AQ
Alzinova appoints Erik Kullgren as interim CFO	03-08	AQ
Alzinova presents at investor meetings in March	03-05	AQ
Alzinova Q4 – With wind in the sails	02-28	AQ
Alzinova publishes Year-end report 2023	02-28	AQ
Alzinova receives regulatory approval to evaluate a higher dose	02-13	AQ
Alzinova: Primary analysis confirms positive phase 1b results with ALZ-101 against Alzheimer’s	01-30	AQ
BioStock: Alzinova's CMO wants to bring forward a vaccine against Alzheimer's	01-08	AQ
Alzinova - Positive topline results	12-04	AQ
Alzinova's CFO plans for retirement and the Company initiates a recruitment process for a successor	12-01	AQ
Alzinova announces positive phase 1b results with the vaccine candidate ALZ-101 against Alzheimer's disease	11-29	AQ
Alzinova presents at Erik Penser Bank's Investor Day on November 23rd	11-20	AQ
Alzinova Q3 - All eyes on the readout	11-02	AQ
Alzinova AB interim report January – September 2023	11-02	AQ
Alzinova engages Erik Penser Bank as liquidity provider	23-10-24	AQ

No results for this search